Situation normale

NS PHARMA
 SRL

5060 Sambreville
Since 27/01/2010
BE0822653238
Financial Health Indicator
7
Equity
€244.3K
+21% YoY
Gross Operating Margin
€229.9K
-8% YoY
EBITDA
€168.1K
-11% YoY
Gain/Loss
€42.3K
-24% YoY
Employees
1

NS PHARMA’s business network visualized

Explore our interactive spiderweb to visually navigate NS PHARMA’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb NS PHARMA
NS PHARMA
  • Nathalie SEVERIN
    5060 Sambreville
    Since 2010

Detailed insights into NS PHARMA’s financial history

See financial trends including, equity, operating income, profit/loss and employees of NS PHARMA. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2024 2023 2022 2021 2020
Equity
244.3K
202.1K
159.8K
127.2K
84.9K
Gross Operating Margin
229.9K
250.9K
240.8K
240.0K
258.5K
Gain/Loss
42.3K
55.8K
46.1K
55.9K
62.7K
Employees
1.2
1.2

Find similar companies like NS PHARMA

Find more companies with similar activities to NS PHARMA from our extensive database.

Frequently asked questions about NS PHARMA

  • Where is NS PHARMA located?

    NS PHARMA’s headquarters is located in Rue d'Auvelais 43 B, 5060 Sambreville.

  • Who are the directors of NS PHARMA?

    NS PHARMA’s directors include
    • Nathalie SEVERIN

  • When was NS PHARMA founded?

    NS PHARMA was founded in 2010-01-27. NS PHARMA has been active for 15 years.

  • What are NS PHARMA’s NACEBEL codes?

    NS PHARMA’s NACEBEL codes are
    • 47730 Commerce de détail de produits pharmaceutiques en magasin spécialisé (2008)

  • What is NS PHARMA’s VAT number?

    NS PHARMA’s VAT number is BE0822653238.

  • What is NS PHARMA’s juridical form?

    NS PHARMA’s juridical type is Société à responsabilité limitée (SRL).

  • How many employees does NS PHARMA have?

    NS PHARMA has 1 employee.

  • How is the financial situation of NS PHARMA?

    openthebox has estimated that NS PHARMA’s financial health score to be 7/10.